Fagan receives lifetime achievement award from Alzheimer’s Association
Anne Fagan, an internationally recognized expert on fluid biomarkers of Alzheimer’s disease and a professor of neurology at the School of Medicine, has been named the 2023 recipient of the Khalid Iqbal Lifetime Achievement Award by the Alzheimer’s Association.
Shedding light on mechanisms behind Alzheimer’s disease
Song Hu at the McKelvey School of Engineering plans to develop deep-brain fiber-optic techniques to investigate the cause of memory loss in Alzheimer’s disease.
How do toxic proteins accumulate in Alzheimer’s and other diseases?
Researchers at the School of Medicine have identified a key step in the development of destructive tau tangles in the brain. The discovery could lead to new approaches to treating a group of neurodegenerative diseases known as tauopathies, such as Alzheimer’s and Parkinson’s.
What to know about the new Alzheimer’s drug Leqembi
The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.
Cognitive function in Down syndrome-associated Alzheimer’s focus of grant
People with Down syndrome are at very high risk of developing Alzheimer’s disease. A project led by Jason Hassenstab, at the School of Medicine, aims to develop tools to measure cognitive function in people with Down syndrome-associated Alzheimer’s disease.
Study defines disparities in memory care
Members of minoritized racial or ethnic groups and people who live in less affluent neighborhoods are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from the School of Medicine indicates.
Tau-based biomarker tracks Alzheimer’s progression
Researchers at the School of Medicine and Lund University in Sweden have identified a form of tau that could serve as a marker to track Alzheimer’s progression. The marker also could speed drug development.
Altered gut bacteria may be early sign of Alzheimer’s disease
A study by researchers at Washington University School of Medicine reveals that the bacteria that live in the gut change long before Alzheimer’s disease symptoms arise. The discovery could lead to diagnostics or treatments for Alzheimer’s disease that target the gut microbiome.
Looking deeper with adaptive six-dimensional nanoscopy
With a $2 million National Institutes of Health (NIH) grant, Matthew Lew at the McKelvey School of Engineering will develop smart microscopes to reveal dynamic interactions between individual biomolecules.
Bateman to receive lifetime achievement award
Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at the School of Medicine, will receive the 2023 Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research.
Older Stories